The Journal of Immunology, Vol 149, Issue 12 3795-3801, Copyright © 1992 by American Association of Immunologists

ARTICLES

CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production

GJ Freeman, DB Lombard, CD Gimmi, SA Brod, K Lee, JC Laning, DA Hafler, ME Dorf, GS Gray and H Reiser
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.

Ag-presenting cells provide at least two distinct signals for T cell activation. T cell receptor-dependent stimulation is provided by presentation of a specific peptide Ag in association with MHC molecules. In addition, APC also supply costimulatory signals required for T cell activation that are neither Ag- nor MHC restricted. One such costimulatory signal is mediated via the interaction of B7 on APC with the CD28 receptor on T cells. Recently, CTLA-4 has been shown to be a second B7 receptor on T cells. In the present report, we have examined the expression of CD28 and CTLA-4 on a panel of resting and activated normal T cell subsets and T cell clones by RNA blot analysis in an attempt to determine whether their expression defines reciprocal or overlapping subsets. CD28 was detected in resting T cells, whereas CTLA- 4 was not. After stimulation with PHA and PMA for 24 h, CTLA-4 mRNA was expressed in both the CD4+ and CD8+ subsets as well as in CD28+ T cells. We examined 37 human and six murine T cell clones that had been previously characterized for their cytokine production. After activation, CTLA-4 and CD28 mRNA were coexpressed in 36 of 37 human T cell clones and all six murine T cell clones. These included T cells of CD4+8-, CD4-8+, and CD4-8- phenotypes as well as clones with Th1 and Th2 cytokine profiles. In contrast, CD28 but not CTLA-4 mRNA was detected in leukemic T cell lines and myelomas. CTLA-4 and B7 mRNA but not CD28 mRNA was detected in two long term HTLV-I-transformed T cell lines. These data demonstrate that CD28 and CTLA-4 mRNA are coexpressed in most activated T cells and T cell clones, providing evidence that they do not define reciprocal subsets. Moreover, they are consistent with the hypothesis that B7 transmits its signal through a single receptor, CD28, on resting T cells, and multiple receptors, CD28 and CTLA-4, on activated T cells.

This article has been cited by other articles:

				K.-Z. Dai, F.-E. Johansen, K. M. Kolltveit, H.-C. Aasheim, Z. Dembic, F. Vartdal, and A. Spurkland Transcriptional Activation of the SH2D2A Gene Is Dependent on a Cyclic Adenosine 5'-Monophosphate-Responsive Element in the Proximal SH2D2A Promoter J. Immunol., May 15, 2004; 172(10): 6144 - 6151. [Abstract] [Full Text] [PDF]

				M. P. Pistillo, P. L. Tazzari, G. L. Palmisano, I. Pierri, A. Bolognesi, F. Ferlito, P. Capanni, L. Polito, M. Ratta, S. Pileri, et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells Blood, January 1, 2003; 101(1): 202 - 209. [Abstract] [Full Text] [PDF]

				L. G. Thebeau and L. A. Morrison B7 Costimulation Plays an Important Role in Protection from Herpes Simplex Virus Type 2-Mediated Pathology J. Virol., March 1, 2002; 76(5): 2563 - 2566. [Abstract] [Full Text] [PDF]

				D. Saverino, A. Merlo, S. Bruno, V. Pistoia, C. E. Grossi, and E. Ciccone Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells J. Immunol., January 1, 2002; 168(1): 207 - 215. [Abstract] [Full Text] [PDF]

				K. Runyon, K. Lee, K. Zuberek, M. Collins, J. P. Leonard, and K. Dunussi-Joannopoulos The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses Blood, April 15, 2001; 97(8): 2420 - 2426. [Abstract] [Full Text] [PDF]

				G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation J. Exp. Med., October 2, 2000; 192(7): 1027 - 1034. [Abstract] [Full Text] [PDF]

				S. J. Faas, M. A. Giannoni, A. P. Mickle, C. L. Kiesecker, D. J. Reed, D. Wu, W. L. Fodor, J. P. Mueller, L. A. Matis, and R. P. Rother Primary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-1 J. Immunol., June 15, 2000; 164(12): 6340 - 6348. [Abstract] [Full Text] [PDF]

				M. L. Baroja, D. Luxenberg, T. Chau, V. Ling, C. A. Strathdee, B. M. Carreno, and J. Madrenas The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation J. Immunol., January 1, 2000; 164(1): 49 - 55. [Abstract] [Full Text] [PDF]

				M. C. Brunner, C. A. Chambers, F. K.-M. Chan, J. Hanke, A. Winoto, and J. P. Allison CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation J. Immunol., May 15, 1999; 162(10): 5813 - 5820. [Abstract] [Full Text] [PDF]

				C.A. CHAMBERS and J.P. ALLISON CTLA-4 -- The Costimulatory Molecule That Doesn't: Regulation of T-cell Responses by Inhibition Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 303 - 312. [Abstract] [PDF]

				G. Boulougouris, J. D. McLeod, Y. I. Patel, C. N. Ellwood, L. S. K. Walker, and D. M. Sansom Positive and Negative Regulation of Human T Cell Activation Mediated by the CTLA-4/CD28 Ligand CD80 J. Immunol., October 15, 1998; 161(8): 3919 - 3924. [Abstract] [Full Text] [PDF]

				M.-L. Alegre, H. Shiels, C. B. Thompson, and T. F. Gajewski Expression and Function of CTLA-4 in Th1 and Th2 Cells J. Immunol., October 1, 1998; 161(7): 3347 - 3356. [Abstract] [Full Text] [PDF]

				G. J. Freeman, A. A. Cardoso, V. A. Boussiotis, A. Anumanthan, R. W. Groves, T. S. Kupper, E. A. Clark, and L. M. Nadler The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor J. Immunol., September 15, 1998; 161(6): 2708 - 2715. [Abstract] [Full Text] [PDF]

				A. Anumanthan, A. Bensussan, L. Boumsell, A. D. Christ, R. S. Blumberg, S. D. Voss, A. T. Patel, M. J. Robertson, L. M. Nadler, and G. J. Freeman Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes J. Immunol., September 15, 1998; 161(6): 2780 - 2790. [Abstract] [Full Text] [PDF]

				P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy CD86 (B7-2) on Human B Cells. A FUNCTIONAL ROLE IN PROLIFERATION AND SELECTIVE DIFFERENTIATION INTO IgE- AND IgG4-PRODUCING CELLS J. Biol. Chem., June 20, 1997; 272(25): 15613 - 15619. [Abstract] [Full Text] [PDF]

				A Shahinian, K Pfeffer, K. Lee, T. Kundig, K Kishihara, A Wakeham, K Kawai, P. Ohashi, C. Thompson, and T. Mak Differential T cell costimulatory requirements in CD28-deficient mice Science, July 30, 1993; 261(5121): 609 - 612. [Abstract] [PDF]